Acutaas Chemicals Limited (NSE:ACUTAAS)

India flag India · Delayed Price · Currency is INR
2,191.90
+33.10 (1.53%)
At close: Mar 2, 2026
102.14%
Market Cap 176.74B
Revenue (ttm) 12.15B
Net Income (ttm) 2.87B
Shares Out 81.87M
EPS (ttm) 34.76
PE Ratio 62.11
Forward PE 48.43
Dividend 1.50 (0.07%)
Ex-Dividend Date Sep 18, 2025
Volume 297,329
Average Volume 361,867
Open 2,058.70
Previous Close 2,158.80
Day's Range 2,055.00 - 2,199.00
52-Week Range 976.55 - 2,200.00
Beta 0.03
RSI 69.33
Earnings Date May 30, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist... [Read more]

Sector Materials
Founded 2004
Employees 879
Stock Exchange National Stock Exchange of India
Ticker Symbol ACUTAAS
Full Company Profile

Financial Performance

In fiscal year 2025, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.

Financial Statements

News

There is no news available yet.